ATTGENO
AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions.
ATTGENO
Social Links:
Industry:
B2B Biotechnology
Founded:
2005-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.attgeno.com
Total Employee:
1+
Status:
Active
Total Funding:
30 M SEK
Technology used in webpage:
Euro Swedish Server Location
Similar Organizations
![]()
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
![]()
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
![]()
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
![]()
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Employees Featured
![]()
Founder
Investors List
![]()
Hadean Ventures
Hadean Ventures investment in Venture Round - AttgeNO
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-08 | Attgeno Appoints Bjรถrn Westberg as CFO |
Official Site Inspections
http://www.attgeno.com
- Host name: webfront4.webcluster.loopia.se
- IP address: 93.188.2.54
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm

More informations about "AttgeNO"
Attgeno
Attgeno About us The Attgeno organisation Board of Directors Management Team Mission & Vision History Our Science Disease Areas Pipeline News Contact See details»
AttgeNO - Crunchbase Company Profile & Funding
AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions. See details»
Attgeno - Leadership Team | The Org
The Leadership Team at Attgeno, comprised of the CEO, Deputy CEO & CMO, CFO, and COO, is responsible for setting the company's strategic direction, overseeing its operational and โฆ See details»
ATTGENO AB, Financial Info, Board and Management, โฆ
SECTOR Super-Sector: Health CareSector: Pharmaceuticals & BiotechnologySub-Sector: Biotechnology KEY FIGURES Employees: Changes In Board and Management in last 6 โฆ See details»
AttgeNO - VentureRadar
AttgeNO AB is a Swedish drug development company founded by world-leading researchers at the Karolinska Institute in Stockholm. The team has found a method of producing completely โฆ See details»
About Attgeno - Health/Medical company in Sweden | F6S
Attgeno - Health/Medical - Developer of innovative and efficient nitric oxide-donating drugs. See details»
The Attgeno organisation
The Attgeno organisation The Attgeno organisation The Attgeno team contains the synthesis of world leading nitric oxide experts and individuals with a record of successful commercialization โฆ See details»
Attgeno Company Profile - Office Locations, Competitors ... - Craft
Attgeno has 1 employees at their 1 location. See insights on Attgeno including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. See details»
Attgeno AB: Drug pipelines, Patents, Clinical trials - Synapse
Jul 20, 2023 Explore Attgeno AB with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 1 news, Technology Platform:Unknown, Drug:Supernitro . See details»
About us โ Attgeno
About us The Company Attgeno AB, home of Supernitro, is a Swedish clinical stage pharmaceutical company founded by a research group at the Karolinska Institute, Stockholm, โฆ See details»
Attgeno - The Org
AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions. See details»
Attgeno Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Attgeno. Use the PitchBook Platform to explore the full profile. See details»
Attgeno CEO and key executive team - Craft.co
Attgeno's Chairman of the Board is Magnus Persson. Other executives include Björn Westberg, CFO; Elisabet Lindberg, Board Member and 3 others. See the full leadership team at Craft. See details»
Attgeno appoints Björn Westberg as CFO - Hadean Ventures
Jul 8, 2021 work with Björn, which includes developing the company so that Attgenoโs organization meets the requirements for listed companies, as a public listing is an alternative โฆ See details»
Management Team โ Attgeno
He is also a senior consultant in psychiatry and an experienced people and organization development manager and lecturer. Per has founded and served as CEO for several โฆ See details»
History โ Attgeno
Attgeno was founded in Stockholm 2005. The company focused on research from the outset until 2015. Under new management (Per Agvald and Christofer Adding), the company started pre โฆ See details»
AttgeNO - Contacts, Employees, Board Members, Advisors & Alumni
AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions. See details»
AttgeNO (company) | Nordic 9
AttgeNO (company). AttgeNO is working on the development of new blood vessel-inducing drugs. Supernitro (PDNO) is a new patented drug candidate for the treatment of acute life threatening โฆ See details»
Our Science โ Attgeno
Our Science Nitric oxide in health and disease Nitric oxide (NO) is a remarkable gas naturally produced by the body, playing a crucial role in improving blood flow and oxygen delivery to โฆ See details»
Development background โ Attgeno
Development background Since the discovery that Nitroglycerin and related compounds operate through the release of nitric oxide (NO), considerable resources have been invested in โฆ See details»